Status:
COMPLETED
INSPIRE Trial for Abdominal Infections
Lead Sponsor:
Harvard Pilgrim Health Care
Collaborating Sponsors:
Hospital Corporation of America
University of California, Irvine
Conditions:
Abdominal (ABD) Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The INSPIRE Abdominal Infection Trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine...
Eligibility Criteria
Inclusion
- Facility
- HCA Healthcare hospitals admitting adults for abdominal infection
- Facility use of MEDITECH as their electronic health record system
- Facility
Exclusion
- \-
- Note: unit of randomization is the hospital, however the computerized physician order entry (CPOE) alert intervention will calculate risk estimates for adults age \>=18 admitted to non-intensive care unit wards and who are ordered to receive extended-spectrum antibiotics for abdominal infection.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2025
Estimated Enrollment :
198480 Patients enrolled
Trial Details
Trial ID
NCT05423743
Start Date
January 1 2023
End Date
May 9 2025
Last Update
August 15 2025
Active Locations (101)
Enter a location and click search to find clinical trials sorted by distance.
1
Riverside Community Hospital
Riverside, California, United States, 92501
2
Regional Medical Center of San Jose
San Jose, California, United States, 95116
3
Good Samaritan Hospital
San Jose, California, United States, 95124
4
Los Robles Hospital & Medical Center
Thousand Oaks, California, United States, 91362